Volume 11, Number 3, March 2005

Ebola Virus Antibody Prevalence in Dogs and Human Risk

Loïs Allela,* Olivier Bourry,* Régis Pouillot,†  André Délicat,* Philippe Yaba,* Brice Kumulungui,* Pierre Rouquet,* Jean-Paul Gonzalez,‡ and Eric M. Leroy*‡
*Centre International de Recherches Médicales de Franceville, Franceville, Gabon; †Centre Pasteur du Cameroun, Yaoundé, Cameroun; and ‡Institut de Recherche pour le Développement, Paris, France

Figure 2. Seroprevalence of Ebola virus in dogs sampled in different areas: A) France, major towns of Gabon, Mekambo (a town close to the disease-epidemic area) and villages in the epidemic area; B) France, major towns of Gabon, Mekambo, villages without human cases and villages with human cases; C) France, major towns of Gabon, Mekambo, villages with and without an animal source. Estimates are represented by squares, bounded by their 95% Clopper and Pearson confidence intervals. The dashed line is the linear trend in proportion.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed February 17, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention